ras and c-myc protein expression in colorectal carcinoma
Tóm tắt
This study was performed to determine the correlation of tumor
ras
and c-myc
oncogene expression with clinical and prognostic variables in patients prone to develop colorectal cancer. One hundred eighteen patients with colorectal cancer were studied; mean age was 40 years. Fifty-three were young patients (age 40 or less), 49 had ulcerative colitis, and 16 had multiple polyposis coli. Immunoperoxidase stains of paraffin-embedded cancer sections were performed for the c-myc
and
ras
proteins.ras
staining was found to correlate with Dukes stage and prognosis. Patients with tumors negative for
ras
protein stain had an actuarial five-year survival of 61 percent versus 44 percent for those tumors with a positive stain (P
<0.05). This correlation was not seen with the c-myc
stain. Positive
ras
oncogene stain appears to be a useful indicator of advanced stage and poor prognosis in colorectal cancer occurring in cancer-prone patients.
Tài liệu tham khảo
Heimann TM, Greenstein AJ, Bolnick K, Yoelson S, Aufses AH. Colorectal cancer in familial polyposis coli and ulcerative colitis. Dis Colon Rectum 1985;28:658–61.
Heimann TM, Bolnick K, Aufses AH. Results of surgical treatment for familial polyposis coli. Am J Surg 1986;152:276–8.
Greenstein AJ, Sachar DB, Smith H,et al. Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology 1979;77:290–4.
Johnson WR, McDermott FT, Hughes ES, Pihl EA, Milne BJ, Price AB. Carcinoma of the colon and rectum in inflammatory disease of the intestine. Surg Gynecol Obstet 1983;156:193–7.
Heimann TM, Oh C, Aufses AH. Clinical significance of rectal cancer in young patients. Dis Colon Rectum 1989;32:473–6.
Adloff M, Arnaud JP, Schoegel M, Thibaud D, Bergamaschi R. Colorectal cancer in patients under 40 years of age. Dis Colon Rectum 1986;29:322–5.
Kerr IB, Spandidos DA, Finlay IG, Lee FD, McArdle CS. The relation of ras family oncogene expression to conventional staging criteria and clinical outcome in colorectal carcinoma. Br J Cancer 1986;53:231–5.
Stewart J, Evan G, Watson J, Sikora K. Detection of the c-myc oncogene product in colonic polyps and carcinomas. Br J Cancer 1986;53:1–6.
Ciclitira PJ, MaCartney JC, Evan G. Expression of c-myc in non-malignant and pre-malignant gastrointestinal disorders. J Pathol 1987;151:293–6.
Michelassi F, Vannucci LE, Montag A, Chappell R, Rodgers J, Block GE. Ras oncogene expression as a prognostic indicator in rectal adenocarcinoma. J Surg Res 1988;45:15–20.
Jass JR, Atkin WS, Cuzick J,et al. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology 1986;10:437–59.
Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954;139:846–51.
Sikora K, Chan S, Evan G,et al. C-myc oncogene expression in colorectal cancer. Cancer 1987;59:1289–95.
Erisman MD, Litwin S, Keidan RD, Comis RL, Astrin SM. Noncorrelation of the expression of the c-myc oncogene in colorectal carcinoma with recurrence of disease or patient survival. Cancer Res 1988;48:1350–5.
Barbacid M. Ras genes. Annu Rev Biochem 1987;56:779–827.
Garin Chesa P, Rettig WJ, Melamed MR, Old LJ, Niman HL. Expression of p21 ras in normal and malignant human tissues: lack of association with proliferation and malignancy. Proc Natl Acad Sci U S A 1987;84:3234–8.
Salhab N, Jones DJ, Bos JL, Kinsella A, Schofield PF. Detection of ras gene alterations and ras proteins in colorectal cancer. Dis Colon Rectum 1989;32:659–64.
Thor A, Horan Hand P, Wunderlich D, Caruso A, Muraro R, Schlom J. Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseases. Nature 1984;311:562–5.
Ruol A, Stephens JK, Maiorana A,et al. Expression of ras oncogene p21 in esophageal squamous cell carcinoma. Surg Forum 1987;38:445–7.
Michelassi F, Erroi F, Roncella M, Block GE. Ras oncogene and the acquisition of metastasizing properties by rectal adenocarcinoma. Dis Colon Rectum 1989;32:665–8.
Pulciani S, Santos E, Long LK, Sorrentino V, Barbacid M. Ras gene amplification and malignant transformation. Mol Cell Biol 1985;5:2836–41.
Thorgeirsson UP, Turpeenniemi-Hujanen T, Williams JE,et al. NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice. Mol Cell Biol 1985;5:259–62.